9β Polymorphism of the glucocorticoid receptor gene appears to have limited impact in patients with Addison's disease.
BACKGROUND: Addison's disease (AD) has been associated with an increased risk of cardiovascular disease. Glucocorticoid receptor polymorphisms that alter glucocorticoid sensitivity may influence metabolic and cardiovascular risk factors in patients with AD. The 9β polymorphism of the glucocorti...
Main Authors: | Ian Louis Ross, Collet Dandara, Marelize Swart, Miguel Lacerda, Desmond Schatz, Dirk Jacobus Blom |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3900528?pdf=render |
Similar Items
-
Cardiovascular risk factors in patients with Addison's disease: a comparative study of South African and Swedish patients.
by: Ian Louis Ross, et al.
Published: (2014-01-01) -
The aetiopathogenesis, cardiovascular and metabolic complications, and pharmacogenomics of Addison's disease in South Africa
by: Ross, Ian Louis
Published: (2015) -
Genetic variation in the 3'-UTR of CYP1A2, CYP2B6, CYP2D6, CYP3A4, NR1I2 and UGT2B7: potential effect on regulation by microRNA and pharmacogenomics relevance
by: Marelize eSwart, et al.
Published: (2014-06-01) -
Addison's disease symptoms--a cross sectional study in urban South Africa.
by: Ian Louis Ross, et al.
Published: (2013-01-01) -
Sleep, Cognition and Cortisol in Addison’s Disease: A Mechanistic Relationship
by: Michelle Henry, et al.
Published: (2021-08-01)